Safety monitoring: An Indian perspective

International Journal of Risk and Safety in Medicine

Volumn 16, Issue 1, 2003, Pages 21-30

  Gogtay, N J ^a   Dalvi, S S ^a   Kshirsagar, N A ^a  

^a KEM HOSPITAL   (India)

Author keywords

Drug safety; Indian health care; Non allopathic medicine; Pharmacovigilance; Post marketing surveillance; Safety regulations; Spontaneous reporting

Indexed keywords

ACETYLSALICYLIC ACID; ARTEMETHER PLUS BENFLUMETOL; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HYPERICUM PERFORATUM EXTRACT; KAVA; NIMESULIDE; PARACETAMOL; TANACETUM PARTHENIUM EXTRACT;

CLINICAL TRIAL; DRUG MANUFACTURE; DRUG SURVEILLANCE PROGRAM; EUROPE; HUMAN; INDIA; LIVER TOXICITY; MALARIA; MEDICAL PRACTICE; MOLECULAR DYNAMICS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; POPULATION RESEARCH; PUBLIC HEALTH SERVICE; QUALITY CONTROL; REVIEW; SIDE EFFECT; STANDARDIZATION; SYRINGE; UNITED KINGDOM; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 0344395247     PISSN: 09246479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. S. Bajaj and S.B. Vohora, Analgesic activity of gold preparations in Ayurveda and Unani, Ind. J. Med. Res. 108 (1998), 104-411.
2. S. Balasubramaniam, N.J. Gogtay and N.A. Kshirsagar, Mortality due to adverse drug reactions in a large general hospital, Nat. Med. J. Ind. 12 (1999), 300.
3. A. Chopra, Ayurvedic medicine and arthritis, Rheumat. Dis. Clin. North Am. 26 (2000), 133-144.
4. E.M. Critchley, Was the thalidomide tragedy preventable?, Lancet 351 (1998), 1591.
5. U.P. Dandekar, R.S. Chandra, S.S. Dalvi, M.V. Joshi, P.C. Gokhale, A.V. Sharma, P.U. Shah and N.A. Kshirsagar, Analysis of a clinically important interaction between phenytoin and shankhapushpi, an ayurvedic preparation, J. Ethnopharmacol. 35 (1992), 285-288.
6. V.R. Dharnidharka, P.N. Kandoth and R.K. Anand, Adverse drug reactions in pediatrics with a study of in hospital intensive surveillance, Ind. Ped. 30 (1993), 745-751.
7. R.I. Edwards and C. Biriell, Harmonization in pharmacovigilance, Drug Safety 10 (1994), 93-102.
8. E. Ernst and M.H. Pittler, The efficacy and safety of feverfew (Tanacetum parthenium L): an update of a systematic review, Pub. Health. Nutr. 3 (2000), 509-514.
9. Ethical guidelines for biomedical research on human subjects, Indian Council of Medical Research, New Delhi, 2000.
10. S.K. Garg, A.S. Islam, N. Kumar, M. Sehgal and V.K. Bhargava, Effect of Mentat on the pharmacokinetics of single and multiple doses of phenytoin in rabbits, Neurol. Ind. 47 (1999), 104-107.
11. N.J. Gogtay, S.S. Dalvi, C.T. Rane, H.S. Powar, R.V. Narayana, P.U. Shah and N.A. Kshirsagar, A story of Ayurvedic tablets and misled epileptic patients, J. Assoc. Phy. Ind. 47 (1999), 1116.
12. N.J. Gogtay, S.S. Mangalvedhekar and N.A. Kshirsagar, Adverse drug reaction monitoring in India and the postal survey as a useful tool for ADR detection, Pharmacoepidemiol and Drug Safety 9 (2000), 235-236.
13. J.M. Greeson, St John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological and clinical literature, Psychopharmacol. 153 (2001), 402-414.
14. S.K. Gupta, T. Kaleekal and S. Joshi, Misuse of corticosteroids in some of the drugs dispensed as preparations from alternative systems of medicine in India, Pharmacoepidemiol & Drug Safety 9 (2000), 599-602.
15. Health Care delivery system in India-Module 1.0, National Institute of Health and Family Welfare, New Delhi, India, 1996.
16. Israel nimesulide suspension enquiry, Scrip 2434 (1999), 23.
17. T.J. John, An ethical dilemma in rabies immunization, Vaccine 15 (1997), S12-S15.
18. S.C. Karande and N.A. Kshirsagar, Adverse drug reactions in children in developing countries, Nat. Med. J. Ind. 9 (1996), 218-221.
19. S.C. Karande and N.A. Kshirsagar, Ciprofloxacin use: acute arthropathy and long term follow up, Ind. Ped. 33 (1996), 910-916.
20. R.S. Karan, S. Malhotra and P. Pandhi, The drug lag: New drug introductions in India in comparison to United States, J. Assoc. Phy. Ind. 50 (2002), 782-787.
21. A. Kar, B.K. Chaudhary and N.G. Bandyopadhyay, Preliminary studies on the inorganic constituents of some indigenous hypoglycaemic herbs on oral glucose tolerance test, J. EthnoPharmacol. 64 (1999), 179-184.
22. G.J. Kontoghiorghes, M.B. Agarwal, R.W. Grady, A. Kolnagou and J.J. Marx, Deferiprone for thalassaemia, Lancet 356 (2000), 428-429.
23. K.V. Kowdley and M.M. Kaplan, Iron chelation therapy with oral deferiprone - toxicity or lack of efficacy?, Lancet 339 (1998), 468-469.
24. N.A. Kshirsagar, S.S. Dalvi, M.V. Joshi, S.S. Sharma, H.M. Sant, P.U. Shah and R.H. Chandra, Phenytoin and Ayurvedic preparation - clinically important interaction in epileptic patients, J. Assoc. Phy. Ind. 40 (1992), 354-355.
25. N.A. Kshirsagar, N.J. Gogtay, N.S. Moorthy, M.R. Garg, S.S. Dalvi, A.R. Chogle, J.S. Sorabjee, S.N. Marathe, G.H. Tilve, A.D. Bhatt, S.P. Sane, R. Mull and I.A. Gathmann, A randomized, double-blind parallel group, comparative safety, and efficacy trial of oral coartemether versus oral chloroquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in adults in India, Am. J. Trop. Med. 62 (2000), 402-408.
26. N.A. Kshirsagar and S.C. Karande, Adverse drug reaction monitoring in pediatric practice, Ind. Ped. 33 (1996), 993-998.
27. N.A. Kshirsagar, Misleading herbal ayurvedic brand name, Lancet 341 (1993), 1595-1596.
28. R.D. Kulkarni, Reporting systems for rare side effects of non narcotic analgesics in India-problems and opportunities, Med. Toxicol. 1(Suppl. 1) (1986), 110-113.
29. W.C. LaFrance, E.C. Lauterbach and C.E. Coffey, The use of herbal alternative medicine in Neuropsychiatry, Clin. Neurosci. 12 (2000), 177-192.
30. R.D. Lele, Ayurveda (ancient Indian system of medicine) and modern molecular medicine, J. Assoc. Phy. Ind. 47 (1999), 625-628.
31. R. Lodha and A. Bagga, Traditional Indian system of medicine, Ann. Acad. Med. Singapore 29 (2000), 37-41.
32. S. Malhotra and P. Pandhi, Analgesics for pediatric use, Ind. J. Ped. 67 (2000), 589-590.
33. S.S. Mangalvedhekar, N.J. Gogtay, J.M. Shah et al., Adverse drug reaction (ADR) postal survey-bronchial asthma and angioedema with nimesulide, J. Assoc. Phy. Ind. 48 (2000), 548.
34. S.S. Mangalvedhekar, N.J. Gogtay, V.R. Wagh, M.S. Waran, D. Mane and N.A. Kshirsagar, Penalties of polytherapy-convulsions in non epileptics due to mefloquine-fluoroquinolone co-administration, Nat. Med. J. Ind. 13 (2000), 47.
35. K. Park, Park's Textbook of Preventive and Social Medicine, 17th edn, M/ S Banarsidas Bhanot Publishers, Jabalpur, India 2001.
36. Portugal suspends pediatric nimesulide, Scrip 2431 (1990), 20.
37. T.V. Sairam, Home Remedies, Vol. IV, Penguin, India, 2002.
38. D.C. Sharma, India raises standards for traditional drugs, Lancet 356 (2000), 231.
39. D.K. Sood, S. Kumar, S. Singh and J. Sokhey, Adverse reactions after measles vaccination in India, Nat. Med. J. Ind. 8 (1995), 208-210.
40. V. Malik, ed., The Drugs and Cosmetics Act, 1940, 8 edn, Eastern Book Company, Lucknow, India, 1996.
41. A.J. Tomossoni and K. Simone, Herbal medicines for children: an illusion of safety?, Curr. Op. Ped. 13 (2001), 162-169.
42. R. Uppal, R. Jhaj and S. Malhotra, Adverse drug reactions among inpatients in a north Indian referral hospital, Nat. Med. J. Ind. 13 (2000), 16-28.
43. L.P. Vaes and P.A. Chyka, Interactions of warfarin with garlic, ginger, gingko or ginseng: Nature of the evidence, Ann. Pharmacother. 34 (2000), 1478-1482.
44. W.M. Wardell, Introduction of new therapeutics in the United States and Great Britain: an international comparison, Clin. Pharmacol. Ther. 14 (1973), 773-790.
45. K. Weerasuriya, Registration of new drugs in developing countries, Lancet 353 (1999), 2161-2162.